The Spanish Agency of Medicines and Medical Devices (Aemps) has confirmed a total of 111 cases of anaplastic large cell lymphoma associated with breast implants (ALCL) up to 2025, a rare type of cancer linked to breast implants. In total, the agency has received 146 suspected reports since it began monitoring this condition in 2012.
The figures appear in the sixth follow-up report on the national protocol for the detection and study of this type of lymphoma, drawn up on the basis of reports registered in the Medical Devices Vigilance System. For years, Aemps has been carrying out specific monitoring of this disease together with medical societies and European health authorities.
Madrid is the autonomous community with the highest number of reports, ahead of Andalusia, Catalonia and the Valencian Community, according to the report released by the agency.
A rare cancer linked to certain implants
Breast implant-associated ALCL, known internationally as BIA-ALCL, is an uncommon type of non-Hodgkin lymphoma that does not originate in breast tissue, but in immune system cells that can develop in the capsule of tissue surrounding the implant.
